Ameriprise
JBIO

Ameriprise’s Jade Biosciences JBIO Stock Holding History

Ameriprise’s Portfolio JBIO Stock Details JBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.38M Buy
+107,053
New +$2.23M ﹤0.01% 2987
2026
Q1 		– Sell
-187,254
Closed -$2.89M – 4062
2025
Q4 		$2.89M Buy
+187,254
New +$2.2M ﹤0.01% 2801

Other funds holding JBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Ameriprise's JBIO Position: Q2 2026 in Review

Ameriprise opened a new position in Jade Biosciences (JBIO) in Q2 2026: 107,053 shares worth $2.38M. The stake represents ﹤0.01% of the portfolio and ranks #2987 among its holdings. This is a return to the name: Ameriprise previously reported a position in JBIO as recently as Q4 2025.

Ameriprise first reported a position in JBIO in Q4 2025 and has held it in 2 quarters since. The position peaked at $2.89M in Q4 2025. 153 funds tracked by Wall St. Rank hold JBIO as of Q2 2026.

  • Ameriprise held 107,053 shares of Jade Biosciences worth $2.38M as of Q2 2026.
  • Jade Biosciences was a new Ameriprise position in Q2 2026.
  • Jade Biosciences made up ﹤0.01% of Ameriprise's portfolio in Q2 2026, its #2987 holding.
  • Ameriprise first reported a position in Jade Biosciences in Q4 2025 and has held it in 2 quarters since.
  • Ameriprise's Jade Biosciences position peaked at $2.89M in Q4 2025.
  • 153 funds tracked by Wall St. Rank held Jade Biosciences as of Q2 2026.

Based on Ameriprise's 13F filing for Q2 2026, filed 14 Aug 2026.